Research Output

Filter
Editorial
2020

Fighting 2 Enemies: Cancer and COVID-19

Vose, J. M., May 13 2020, In : Oncology (Williston Park, N.Y.). 34, 5, 1 p.

Research output: Contribution to journalEditorial

2018

Predictive biomarkers for immune checkpoint inhibitor therapy: We need to keep searching

Huerter, M. M. & Ganti, A. K., Jul 1 2018, In : Journal of Thoracic Disease. 10, p. S2195-S2197

Research output: Contribution to journalEditorial

2 Scopus citations
2017

Bevacizumab in extensive-disease small cell lung cancer: The search continues

Kallam, A. & Ganti, A. K. P., May 1 2017, In : Translational Cancer Research. 6, p. S537-S538

Research output: Contribution to journalEditorial

1 Scopus citations

Delivery of personalized medicine with precision

Hayes, D. F. & Vose, J. M., 2017, In : JCO Precision Oncology. 2017, 1, p. 1-3 3 p.

Research output: Contribution to journalEditorial

Surgery for limited-stage small cell lung cancer: Ready for prime-time?

Ernani, V. & Ganti, A. K., Oct 1 2017, In : Journal of Thoracic Disease. 9, 10, p. 3576-3578 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Which anti-CD20 antibody is better in follicular lymphoma?

Armitage, J. O. & Longo, D. L., Oct 5 2017, In : New England Journal of Medicine. 377, 14, p. 1389-1390 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2016

Evolution

Cox, J. V. & Armitage, J. O., Jan 2016, In : Journal of oncology practice. 12, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Relapsed small cell lung cancer: Is more better?

Ernani, V. & Ganti, A. K., 2016, In : Translational Cancer Research. 5, p. S1363-S1365

Research output: Contribution to journalEditorial

Resected small cell lung cancer-what do we do next?

Marr, A. S. & Ganti, A. K., Aug 2016, In : Annals of Translational Medicine. 4, 15, 288.

Research output: Contribution to journalEditorial

1 Scopus citations
2015

Controversies in the treatment of early-stage Hodgkin's lymphoma

Longo, D. L. & Armitage, J. O., Apr 23 2015, In : New England Journal of Medicine. 372, 17, p. 1667-1669 3 p.

Research output: Contribution to journalEditorial

12 Scopus citations

Genetic cancer susceptibility testing: Increased technology, increased complexity

Yu, P. P., Vose, J. M. & Hayes, D. F., Nov 1 2015, In : Journal of Clinical Oncology. 33, 31, p. 3533-3534 2 p.

Research output: Contribution to journalEditorial

8 Scopus citations

Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

Lunning, M. A. & Armitage, J. O., Jul 6 2015, In : Haematologica. 100, 7, p. 853-855 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations

To Surveil or Not to Surveil

Armitage, J. O. & Vose, J. M., Dec 1 2015, In : Journal of Clinical Oncology. 33, 34, p. 3983-3984 2 p.

Research output: Contribution to journalEditorial

7 Scopus citations
2014

Grade II gliomas-not so low grade

Shonka, N. A., Dec 1 2014, In : Oncology (Williston Park, N.Y.). 28, 12, 1 p.

Research output: Contribution to journalEditorial

Improving breast cancer therapy with CDK4/6 inhibitors

Jaganathan, H., Overstreet, K. & Reed, E., Dec 1 2014, In : Clinical Breast Cancer. 14, 6, p. 379-380 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations
2013

Molecular advances come of age

Jacobs, P., Wood, L. & Armitage, J. O., Aug 2013, In : Transfusion and Apheresis Science. 49, 1, p. 6-8 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Molecular advances come of age (Part II)

Jacobs, P., Wood, L. & Armitage, J. O., Oct 2013, In : Transfusion and Apheresis Science. 49, 2, p. 107-109 3 p.

Research output: Contribution to journalEditorial

2012

From the guest editor: Pressing questions in the care of patients with lymphomas

Armitage, J. O., Sep 2012, In : Cancer Journal (United States). 18, 5, p. 381-382 2 p.

Research output: Contribution to journalEditorial

Who benefits from surveillance imaging?

Armitage, J. O., Jul 20 2012, In : Journal of Clinical Oncology. 30, 21, p. 2579-2580 2 p.

Research output: Contribution to journalEditorial

17 Scopus citations
2011

25 years later: Endangered species or successful evolution?

Armitage, J. O., Davidson, N. E., Janjan, N. & Wood, W. C., 2011, In : ONCOLOGY. 25, 14, 3.

Research output: Contribution to journalEditorial

Relapsed diffuse large B-cell lymphoma: Clinical utility of cell of origin

Vose, J. M., Nov 1 2011, In : Journal of Clinical Oncology. 29, 31, p. 4065-4066 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2010

Proceedings of the 13th biennial South African Lymphoma Study Group Meeting - Cape Town October 2008

Armitage, J. O., Diehl, V., Engert, A., Jacobs, P. & Wood, L., Apr 2010, In : Transfusion and Apheresis Science. 42, 2, p. 125-128 4 p.

Research output: Contribution to journalEditorial

2009

Targeted therapy and hematological malignancy

Armitage, J. O., Jan 2009, In : Targeted Oncology. 4, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Vascular medicine: A look forward

Holstein, S. A. & Hohl, R. J., Aug 2009, In : Clinical Pharmacology and Therapeutics. 86, 2, p. 117-119 3 p.

Research output: Contribution to journalEditorial

2008

Diffuse large B-cell lymphoma of the breast: A distinct entity?

Bierman, P. J., Villanueva, M. L. & Armitage, J. O., Feb 2008, In : Annals of Oncology. 19, 2, p. 201-202 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2007

Proceedings of the 12th Biennial Congress - South African Lymphoma Study Group

Jacobs, P., Wood, L. & Armitage, J. O., Aug 2007, In : Transfusion and Apheresis Science. 37, 1, p. 27-29 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2006

Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas

Fisher, R. I., Coiffier, B. & Vose, J. M., Apr 2006, In : Clinical Advances in Hematology and Oncology. 4, 4 SUPPL. 10, p. 1+3

Research output: Contribution to journalEditorial

Any drug that works has a target

Armitage, J. O., Oct 2006, In : Targeted Oncology. 1, 4, p. 179-180 2 p.

Research output: Contribution to journalEditorial

Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?

Armitage, J. O. & Loberiza, F. R., Jun 2006, In : Annals of Oncology. 17, 6, p. 883-884 2 p.

Research output: Contribution to journalEditorial

19 Scopus citations

Purine analogues in the treatment of lymphoid malignancies

Foss, F., Vose, J. M., Neumann, M. & Harris, M. E., Apr 2006, In : Seminars in hematology. 43, SUPPL. 2, p. S1

Research output: Contribution to journalEditorial

2005

Defining the stages of aggressive non-Hodgkin's lymphoma - A work in progress

Armitage, J. O., Mar 24 2005, In : New England Journal of Medicine. 352, 12, p. 1250-1252 3 p.

Research output: Contribution to journalEditorial

8 Scopus citations

Screening for dihydropyrimidine dehydrogenase deficiency

Grem, J. L., Jul 15 2005, In : Clinical Cancer Research. 11, 14, p. 5067-5068 2 p.

Research output: Contribution to journalEditorial

12 Scopus citations
2004

Adjuvant therapy for colon cancer: A historical perspective

Grem, J., Aug 4 2004, In : Journal of the National Cancer Institute. 96, 15, p. 1116-1117 2 p.

Research output: Contribution to journalEditorial

Open Access
3 Scopus citations

Mature results of adjuvant colon cancer trials from the Fluorouracil-only era

Grem, J. L., May 19 2004, In : Journal of the National Cancer Institute. 96, 10, p. 727-729 3 p.

Research output: Contribution to journalEditorial

Open Access
4 Scopus citations

Seminars in Oncology: Introduction

Armitage, J. O., Dec 2004, In : Seminars in Oncology. 31, SUPPL. 16, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Towards understanding the peripheral T-cell lymphomas

Armitage, J. O., Vose, J. M. & Weisenburger, D. D., Oct 2004, In : Annals of Oncology. 15, 10, p. 1447-1449 3 p.

Research output: Contribution to journalEditorial

54 Scopus citations
2003

Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma

Juweid, M., DeNardo, G. L., Graham, M. & Vose, J., 2003, In : Cancer Biotherapy and Radiopharmaceuticals. 18, 5, p. 673-674 2 p.

Research output: Contribution to journalEditorial

9 Scopus citations
2002

Combination therapy for non-Hodgkin’s lymphoma: An opportunity for pharmaceutical care in a specialty practice

Augustine, S. C., Norenberg, J. P., Colcher, D. M., Vose, J. M., Gobar, L. S., Dukat, V. J., Hohenstein, M. A., Rutar, F. J., Jacobson, D. A. & Tempero, M. A., 2002, In : Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 42, 1, p. 93-100 8 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Editorial

Armitage, J. O., 2002, In : Clinical lymphoma. 2, 4, p. 200-201 2 p.

Research output: Contribution to journalEditorial

2001

Editorial [1]

Armitage, J. O., 2001, In : Clinical lymphoma. 2, 1, 1 p.

Research output: Contribution to journalEditorial

2000

Myelodysplasia and acute leukemia after autologous bone marrow transplantation

Armitage, J. O., 2000, In : Journal of Clinical Oncology. 18, 5, p. 945-946 2 p.

Research output: Contribution to journalEditorial

23 Scopus citations
1999

Stem cell transplant at home: Glimpse of the future

Reed, E. & Armitage, J. O., 1999, In : Annals of Oncology. 10, 5, p. 493-494 2 p., 10.5.493.

Research output: Contribution to journalEditorial

The contribution of autologous transplant in lymphoma

Kessinger, A., Bociek, G. & Bierman, P., 1999, In : Haematologica. 84, 7, p. 577-579 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations
1997

Drug resistance markers: Are they had or good?

Morrow, C. & Cowan, K. H., 1997, In : Annals of Oncology. 8, 4, p. 314-315 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Economic analyses of new technologies: The case of stem-cell transplantation

Waters, T. M., Bennett, C. L. & Vose, J. M., 1997, In : Journal of Clinical Oncology. 15, 1, p. 2-4 3 p.

Research output: Contribution to journalEditorial

13 Scopus citations

The changing classification of non-Hodgkin's lymphomas

Armitage, J. O., 1997, In : Ca-A Cancer Journal for Clinicians. 47, 6, p. 323-325 3 p.

Research output: Contribution to journalEditorial

Open Access
17 Scopus citations
1995

Treatment for non-hodgkin's lymphoma in relapse – what are the alternatives?

Vose, J. M., Dec 7 1995, In : New England Journal of Medicine. 333, 23, p. 1565-1566 2 p.

Research output: Contribution to journalEditorial

11 Scopus citations

Treatment strategies for patients with relapsed or refractory Hodgkin's disease

Armitage, J. O., Jul 1995, In : Annals of Oncology. 6, 6, p. 517-518 2 p.

Research output: Contribution to journalEditorial

Open Access
7 Scopus citations
1994

Editorial: Autologous transplantation for Hodgkin's disease: Coming of age?

Bierman, P. J., Vose, J. M. & Armitage, J. O., 1994, In : Blood. 83, 5, p. 1161-1164 4 p.

Research output: Contribution to journalEditorial

Open Access
40 Scopus citations